Blue­bird tweaks part­ner­ship with Lon­za to boost Zyn­te­glo, Skysona man­u­fac­tur­ing ca­pac­i­ty

Blue­bird bio is amend­ing its deal with Lon­za for the Swiss CD­MO to boost the man­u­fac­tur­ing ca­pac­i­ty of blue­bird’s ap­proved gene ther­a­pies Zyn­te­glo and Skysona …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER